Endotoxin, inflammation, and intestinal function in livestock by Mani, Venkatesh et al.
Animal Science Publications Animal Science
5-2012
Endotoxin, inflammation, and intestinal function in
livestock
Venkatesh Mani
Iowa State University, manivenkateshm@gmail.com
Thomas E. Weber
United States Department of Agriculture
Lance H. Baumgard
Iowa State University, baumgard@iastate.edu
Nicholas K. Gabler
Iowa State University, ngabler@iastate.edu
Follow this and additional works at: http://lib.dr.iastate.edu/ans_pubs
Part of the Agriculture Commons, and the Meat Science Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
ans_pubs/35. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Animal Science at Digital Repository @ Iowa State University. It has been accepted for
inclusion in Animal Science Publications by an authorized administrator of Digital Repository @ Iowa State University. For more information, please
contact digirep@iastate.edu.
V. Mani, T. E. Weber, L. H. Baumgard and N. K. Gabler
intestinal function in livestock
GROWTH AND DEVELOPMENT SYMPOSIUM: Endotoxin, inflammation, and
doi: 10.2527/jas.2011-4627 originally published online January 13, 2012
2012, 90:1452-1465.J ANIM SCI 
http://www.journalofanimalscience.org/content/90/5/1452
the World Wide Web at: 
The online version of this article, along with updated information and services, is located on
www.asas.org
 at Serials Acquisitions Dept on April 6, 2014www.journalofanimalscience.orgDownloaded from 
1452
ABSTRACT: Endotoxin, also referred to as 
lipopolysaccharide (LPS), can stimulate localized or sys-
temic infl ammation via the activation of pattern recognition 
receptors. Additionally, endotoxin and infl ammation can 
regulate intestinal epithelial function by altering integrity, 
nutrient transport, and utilization. The gastrointestinal tract 
is a large reservoir of both gram-positive and gram-nega-
tive bacteria, of which the gram-negative bacteria serve as 
a source of endotoxin. Luminal endotoxin can enter circu-
lation via two routes: 1) nonspecifi c paracellular transport 
through epithelial cell tight junctions, and 2) transcellular 
transport through lipid raft membrane domains involving 
receptor-mediated endocytosis. Paracellular transport of 
endotoxin occurs through dissociation of tight junction 
protein complexes resulting in reduced intestinal barrier 
integrity, which can be a result of enteric disease, infl amma-
tion, or environmental and metabolic stress. Transcellular 
transport, via specialized membrane regions rich in glyco-
lipids, sphingolipids, cholesterol, and saturated fatty acids, 
is a result of raft recruitment of endotoxin-related signaling 
proteins leading to endotoxin signaling and endocytosis. 
Both transport routes and sensitivity to endotoxin may be 
altered by diet and environmental and metabolic stresses. 
Intestinal-derived endotoxin and infl ammation result in 
suppressed appetite, activation of the immune system, and 
partitioning of energy and nutrients away from growth 
toward supporting the immune system requirements. In 
livestock, this leads to the suppression of growth, particu-
larly suppression of lean tissue accretion. In this paper, we 
summarize the evidence that intestinal transport of endo-
toxin and the subsequent infl ammation leads to decrease 
in the production performance of agricultural animals and 
we present an overview of endotoxin detoxifi cation mecha-
nisms in livestock.
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INTRODUCTION
Growth performance of agricultural animals in 
commercial settings is affected by various physical, so-
cial, and microbial factors that may predispose animals 
to physiological or immunological stresses (Holck et 
al., 1998). Among the stressors that can attenuate the 
growth performance of animals are viruses, live bacte-
ria, and dead bacteria that contain cell wall compounds 
such as lipopolysaccharide (LPS) and peptidogly-
cans (Schinckel et al., 1995; Smith, 1998). Specifi c 
to the focus of this review, we discuss LPS, otherwise 
referred to as endotoxin, the cell wall component of 
gram-negative bacteria that is a potent immune stimu-
lator in livestock (Webel et al., 1997; Kimball et al., 
2003). Importantly, the gastrointestinal tract (GIT) of 
animals serves both as a major barrier to, and major 
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source of, endotoxin (Ravin et al., 1960; Schweinburg 
and Fine, 1960; Wiznitzer et al., 1960).
Endotoxin in mammals is recognized by various cells 
expressing the pattern recognition receptor, toll like recep-
tor (TLR) 4, and other proteins including LPS binding 
protein (LBP), cluster of differentiation 14 (CD14), and 
myeloid differential protein 2 (MD2). These proteins and 
receptors are also present in intestinal epithelial cells and 
have been associated with the transport of luminal endo-
toxin into circulation (Hornef et al., 2003; Neal et al., 2006). 
Once in the systemic circulation, endotoxin can be deacti-
vated or detoxifi ed by immune cells, such as macrophages, 
or Kupffer cells present in the liver or splenic cells or by 
binding with acute phase proteins (Rutenburg et al., 1967; 
Satoh et al., 2008; Buttenschoen et al., 2010). However, if 
there is failure of systemic detection and deactivation, in-
creased circulating concentrations of endotoxin can lead 
to local and systemic infl ammation and, if severe enough, 
endotoxemia and even death (Zweifach and Janoff, 1965; 
Rice et al., 2003). The importance of endotoxin to livestock 
production is that chronic activation of the immune sys-
tem has been shown to antagonize the growth and perfor-
mance of animals because nutrients are being partitioned 
toward production of cytokines, acute phase proteins, and 
other immune modulators rather than toward the anabolic 
processes that support milk and muscle synthesis (Johnson, 
1997; Spurlock, 1997). Further, endotoxin can lead to vari-
ous diseases, including colic and laminitis, and endotox-
emia is a leading cause of death in equine species (Sykes 
and Furr, 2005; Werners et al., 2005). Lipopolysaccharide 
has also been shown to activate the heterophils and upregu-
late the proinfl ammatory cytokine and chemokine expres-
sion in poultry (Kogut et al., 2005).
Interestingly, transport of endotoxin from the intestine 
has been shown to be modulated by dietary factors as well 
as by stressors, including heat stress, systemic disease, and 
feed restriction or malnutrition (Hall et al., 2001; Cani and 
Delzenne, 2010). The major dietary factor that appears to 
modulate the transport of luminal endotoxin is dietary fat. 
As indicated in the biomedical and human health literature, 
as the percentage of dietary fat increases, so does the con-
centration of circulating endotoxin (Erridge et al., 2007; 
Amar et al., 2008). Supporting this notion, we recently 
found that feeding young pigs a high fat diet increases se-
rum endotoxin (V. Mani and N. K. Gabler, unpublished 
data). Further, the form of the lipid ingested may modulate 
the endotoxin transport, with emulsifi ed lipids increasing 
endotoxin transport (Mani and Gabler, 2010; Mani et al., 
2010; Laugerette et al., 2011). In ruminants, feeding eas-
ily digestible carbohydrates and grains has been shown 
to increase the transport of endotoxin to the peripheral 
circulation, indicating that carbohydrates also infl uence 
endotoxin transport (Khafi pour et al., 2009; Zebeli et al., 
2011). In addition to dietary nutrients, systemic increases 
in intestinally derived endotoxin can be attributed to en-
vironmental and immunological stressors. Hyperthermia 
increases intestinal permeability and, presumably, intesti-
nal endotoxin transport (Lambert, 2004, 2008; Pearce et 
al., 2011). Plasma antibodies to endotoxin are inversely 
related to growth in malnourished young children and are 
associated with increased intestinal permeability and sys-
temic immune system activation (Campbell et al., 2003). 
Further studies are warranted to investigate the relation-
ship between endotoxin and growth in livestock.
ENDOTOXIN
Lipopolysaccharide is a glycolipid present in the 
outer membrane of gram-negative bacterial cell wall. 
Lipopolysaccharide consists of a hydrophobic domain, 
lipid A, through which it is inserted into the bacterial cell 
wall, a core oligosaccharide, and a distal oligosaccharide 
(Elin and Wolff, 1976; Raetz and Whitfi eld, 2002). The 
hydrophobic lipid A domain is the most biologically ac-
tive portion of the LPS molecule and it is synonymously 
known as endotoxin because of its toxic nature (Erridge 
et al., 2002). In a typical Escherichia coli, lipid A contains 
the following structural properties: 1) the backbone of the 
lipid A contains diglucosamine, which is phosphorylated 
at positions 1′ and 4′; 2) two 3-hydroxymyristate mole-
cules are directly attached to each glucosamine; and 3) 
at positions 2′ and 3′, the hydroxyl groups of the fatty ac-
ids are substituted by laurate and myristate and they form 
an acyloxyacyl bond with the primary fatty acid chains 
(Figure 1). Diphosphorylated hexaacyl lipid A molecules 
have been shown to be effective stimulators of the immune 
system because they have been optimally recognized by 
the mammalian immune system. Monophosphorylated or 
dephosphorylated endotoxin molecules have been shown 
to substantially lose their potency and immune reactivity 
(Holst et al., 1996; Munford, 2005). Another important 
characteristic of lipid A is that mostly all the fatty acyl 
chains are made up of saturated fatty acids (SFA). If the 
SFA are replaced with unsaturated fatty acids, the endo-
toxin molecule causes an attenuated immune response 
and becomes less of an immune stimulant (Munford and 
Hall, 1986; Kitchens et al., 1992).
Endotoxin can enter systemic circulation from live 
bacteria, leading to septicemia, or as cell wall compo-
nents of dead bacteria. Either way, if the amounts are too 
great, they can ultimately antagonize anabolic growth 
(Kimball et al., 2003; Orellana et al., 2007) or lead to sep-
tic shock and death (Moore and Morris, 1992). Endotoxin 
is released during bacterial death and during growth and 
division, making it a ubiquitous contaminant (Petsch and 
Anspach, 2000; Yaron et al., 2000). The biological activity 
of the endotoxin is measured in endotoxin units (EU). For 
example, 100 pg of endotoxin is considered to have 1 EU, 
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and 10 EU is equivalent to 1 ng of endotoxin. A single 
gram-negative bacterium contains approximately 10−15 g 
of LPS, and 105 bacteria can generate 1 EU. It has been 
shown that a single E. coli contains approximately 106 
lipid A residues (Raetz et al., 1991). Furthermore, the size 
of the individual endotoxin molecules varies between 10 
and 20 kDa in monomeric form and, because of the am-
phiphilic nature, they can arrange themselves into large 
micellar structure achieving 1,000 kDa.
GASTROINTESTINAL FUNCTION
The lumen of the GIT is considered a space out-
side the body because of its continuity with the exter-
nal environment. It has the arduous task of absorbing 
the nutrients that are essential for the organism while 
preventing the absorption of substances that are not 
needed and are harmful to the system. The GIT primar-
ily serves two important functions: absorbing nutrients 
from the lumen and forming a barrier between the lu-
minal contents and systemic circulation. Primarily, the 
intestines aid in the digestion and absorption of proteins, 
carbohydrates, lipids, vitamins, minerals, and water. A 
single layer of intestinal epithelial cells (IEC), which 
line the intestine, selectively absorbs most of the nutri-
ents needed through active and passive processes with 
the help of specifi c transport or carrier proteins. For ex-
ample, glucose and fructose are absorbed through Na-
dependent glucose transporter 1 and glucose transporter 
5, respectively. Water is absorbed through aquaporin 
Figure 1. Simplifi ed structure of lipopolysaccharide (LPS) from gram-negative bacteria such as Escherichia coli. Lipopolysaccharide contains a distal “O” 
polysaccharide region, a core polysaccharide region divided into outer and inner core and an interior lipid A component through which LPS is inserted into the cell 
membrane. “O” polysaccharide region is highly variable and contains approximately 10 to 25 repeated units and is made up of common hexose (Hex) sugars. Outer 
core polysaccharide contains common hexose sugars such as glucose (Glc) and galactose (Gal), whereas inner core polysaccharide contains unusual sugar such as 
3-deoxy-D-manno-octulosonic acid (Kdo) . Lipid A structure is explained in the text. Arrows labeled alkaline phosphatase (AP) and acyloxyacyl hydrolase (AOAH) 
indicate the cleavage points where these enzymes cleave the phosphate and secondary fatty acyl chains, respectively. GlcN = N-acetyl glucosamine; Hep = Heptose. 
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receptors, and amino acids and di- and tripeptides are 
absorbed through numerous transporter proteins located 
on the apical and basolateral membranes. Additionally, 
the GIT serves as a major excretory organ that helps in 
waste products, including excessive nutrients and toxic 
substances secreted by the biliary system. This task be-
comes more diffi cult because only a single layer of IEC 
serves as a barrier. The IEC form a membrane that acts 
as a selective permeability barrier, which can selectively 
allow substances from the lumen.
The epithelial or intestinal integrity is critical for 
maintaining a physical barrier between the intestinal lu-
men and the body. This is dependent largely on the junc-
tion complexes connecting enterocytes together and is 
achieved via a well-organized intercellular array of tight 
junctions, adhesion junctions, and desmosomes sur-
rounding the apical region of epithelial cells. Cell-to-cell 
adhesion and tight junctions are regulated by the mem-
brane-spanning proteins claudin, occludin, zonula occu-
dens (ZO) 1 and 2, and cingulin (Oswald, 2006; Turner, 
2006). Additionally, adhesion junction proteins, such as 
E-cadherin, contribute to gut integrity. Tight junctions 
are the most apical junctions between 2 epithelial cells 
that are formed by claudin and occludin family protein 
strands along with other protein complexes (Denker and 
Nigam, 1998; Chiba et al., 2008). It is becoming clear 
that different claudin isoforms participate in intestinal 
barrier function. Together, claudin and occludin proteins 
are attached to actin cytoskeleton through other proteins, 
such as ZO-1 and junction adhesion molecules (Nusrat 
et al., 2000; Turner, 2006). It was initially thought that 
tight junctions form a physical barrier without any cel-
lular regulation, but recent research indicates that tight 
junction proteins are very well regulated; intracellular 
translocation of tight junction proteins from the cell 
membrane and back occurs regularly during normal cel-
lular processes (Shen et al., 2011).
ENDOTOXIN SIGNALING AND TRANSPORT
Innate immune response is the fi rst line of defense 
against infectious diseases, is mediated by white blood 
cells such as neutrophils and macrophages, and is 
thought to be nonspecifi c (Aderem and Ulevitch, 2000). 
However, a series of discoveries in the late 1990s proved 
this theory wrong (Medzhitov et al., 1997). Specifi c re-
ceptors present in immune cells, such as macrophages, 
dendritic cells, B-cells, and certain types of T-cells, could 
recognize a particular pattern in the invading microbes; 
these receptors came to be known as pattern recognition 
receptors (Medzhitov, 2001; Janeway and Medzhitov, 
2002). Moreover, myocytes and adipocytes also express 
these same pattern recognition receptors (Gabler and 
Spurlock, 2008). The ‘patterns’ present in the differ-
ent microbial species are essential for their survival and 
have come to be known as pathogen-associated molecu-
lar patterns, later renamed microbe-associated molecular 
patterns (MAMP), to include all the microbes, including 
pathogens and nonpathogens (Ausubel, 2005; Akira et 
al., 2006). Pattern recognition receptors sense the pres-
ence of a variety of molecules from the invading patho-
gens, as well as commensals, and regulate the immune 
response by stimulating the secretion of various immune 
mediators (Brikos and O’Neill, 2008). More recently, 
pattern recognition receptors have been shown to recog-
nize not only the pathogenic patterns but also commen-
sals, as well as cellular degradation products from the 
same organism, which are known as damage-associated 
molecular patterns (Chen and Nuñez, 2010; Rosin and 
Okusa, 2011). The fi rst toll pattern recognition recep-
tor to be identifi ed was TLR4, which recognizes bacte-
rial endotoxin and other proteins, including heat shock 
proteins (Poltorak et al., 1998). At present, there are 11 
human and 13 murine TLR, which recognize different 
pathogen components, including fl agella, peptidogly-
can, double-stranded RNA, and DNA (McGettrick and 
O’Neill, 2010; Moresco et al., 2011).
The presence of endotoxin is not sensed by TLR4 
alone. Endotoxin is usually present as an aggregate bound 
to other endotoxin molecules on which LBP acts and 
separates a monomer, which is then presented to CD14. 
The CD14 receptor is present in two forms: membrane 
bound or soluble. The CD14 protein does not have an 
intracellular domain, so it associates with TLR4, which 
has a toll-IL 1 receptor intracellular domain (Beutler, 
2000; Triantafi lou and Triantafi lou, 2002). Toll-like re-
ceptor 4 then dimerizes and binds with myeloid differ-
ential protein 2, which transmits the signal through the 
toll-IL 1 receptor intracellular domain through two path-
ways. One is a myeloid differentiation factor 88-depen-
dent pathway and the other is a myeloid differentiation 
factor 88-independent pathway. The fi rst pathway leads 
to translocation of nuclear factor kappa β to the nucleus 
and the initiation of gene transcription of infl ammatory 
mediators. Alternately, the independent pathway leads 
to the activation of interferon regulatory factor 3 as well 
as nuclear factor kappa β (Verstrepen et al., 2008; Coll 
and O’Neill, 2010). Basically, both pathways lead to the 
secretion and stimulation of proinfl ammatory cytokines 
and other immune mediators. The signaling is quenched 
by endocytosis of TLR4, along with LPS, to an endo-
some where it is then degraded (Saitoh, 2009).
Current research indicates that apart from the sig-
naling proteins, lipid rafts are essential for the TLR4 
signaling and transport to occur (Pfeiffer et al., 2001; 
Triantafi lou et al., 2002, 2004; Olsson and Sundler, 2006). 
Lipid rafts are specialized membrane domains, which 
are rich in SFA, cholesterol, and sphingolipids (Brown 
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and London, 1998; Pike, 2003). These specialized do-
mains have been shown to act as a membrane signal-
ing hub for many receptors and have been implicated in 
forming the signaling complex in T-cell signaling (Janes 
et al., 2000; He and Marguet, 2008). Interestingly, TLR4 
has been shown to be localized to these membrane raft 
domains upon endotoxin stimulation, and disruption of 
endotoxin signaling occurs if the lipid raft is dissociated 
(Triantafi lou et al., 2002).
Circulating endotoxin can be derived from the en-
vironment where the bacteria can be ingested along 
with feed and water or through respiration (Spaan et al., 
2006). The other source is the commensal bacteria in the 
GIT, which is a rich source of gram-negative organisms 
(Wiznitzer et al., 1960; Ley et al., 2006). The bacterial 
population is very scarce in the stomach because of the 
acidic environment, but the numbers increase exponen-
tially down the intestinal tract from duodenum to colon 
(Tlaskalová-Hogenová et al., 2004; Magalhaes et al., 
2007). The main entry point for pathogenic bacteria, en-
dotoxin, mycotoxin, and other pathogens is via the di-
gestive tract. Thus, the intestines form a major physical 
barrier to prevent pathogens and toxic compounds from 
entering the mucosa and circulation and then activating 
the immune system.
The luminal transport of endotoxin to the systemic cir-
culation is not fully understood, but 2 primary routes ex-
ist. The fi rst route is through paracellular transport, where 
the transport of endotoxin occurs through tight junctions 
formed between 2 intestinal epithelial cells (Drewe et al., 
2001; Hietbrink et al., 2009). Various factors have been 
shown to regulate the permeability of the intestinal tight 
junction barrier (Shen et al., 2011). When animals are un-
der stress or have intestinal infl ammation, small quantities 
of luminal contents, endotoxin, and pathogens may enter 
the epithelium and circulation through the tight junctions. 
These pathogens and MAMP can stimulate the localized 
secretion of proinfl ammatory cytokines, including tumor 
necrosis factor (TNF)-α and IL-1β from immune and in-
testinal epithelial cells. Consequently, these infl ammatory 
and stress responses may cause the phosphorylation of 
myosin light chain by myosin light chain kinase, which 
results in the contraction and opening of the intestinal 
epithelial tight junctions and increases intestinal perme-
ability (Turner et al., 1997; Moriez et al., 2005; Chen et 
al., 2006; Turner, 2009).
Disruption of tight junctions and increased paracel-
lular permeability by oxidative stress has been demon-
strated in IEC. Treating Caco-2 intestinal epithelial-like 
cells with the oxidant hydrogen peroxide, increases bar-
rier permeability and leads to a redistribution of ZO-1 
and occludin (Sheth et al., 2009). Interestingly, Caco-2 
cell monolayers treated with endotoxin increases lipid 
peroxidation and paracellular permeability (Courtois et 
al., 2003). The increased permeability can be reversed 
by treatment with the antioxidant butylated hydroxytolu-
ene. This indicates that endotoxin itself can decrease in-
testinal barrier function by a mechanism that is mediated 
by oxidative stress. Further indicating a link between re-
dox status and intestinal barrier function is the fi nding 
that treating Caco-2 cells with bile acid (i.e., cholic acid) 
increases paracellular permeability by increasing reac-
tive oxygen species (Araki et al., 2005). Blocking the 
increase in reactive oxygen species with the antioxidant 
n-acetyl cysteine prevents the decrease in transepithelial 
electrical resistance (TER) in bile acid-treated IEC. Bile 
acid treatment leads to redistribution of ZO-1 and oc-
cludin and the increased permeability can be reversed by 
1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-
diazepine hydrochloride, a myosin light chain kinase 
inhibitor, indicating a linkage between cellular redox 
status and tight junctions.
Under normal physiological conditions, tight junc-
tion barrier integrity remains intact and luminal contents 
and transport of molecules across the tight junctions 
is very well regulated (Edelblum and Turner, 2009). 
Nevertheless, metabolic stress and environmental stress-
es, such as heat stress, have been reported to cause in-
creased intestinal permeability or “leaky gut” (Lambert 
et al., 2002; Lambert, 2004; Singleton and Wischmeyer, 
2006). However, the pathways through which tight junc-
tion proteins are regulated by these conditions are not 
fully characterized.
Intestinal and systemic diseases are associated with 
leaky epithelial barrier and increased intestinal perme-
ability to endotoxin. The TER of cell monolayers or in-
testinal epithelial membranes is a good indicator of the 
degree of tight junction organization and gut integrity. 
Pigs challenged with endotoxin showed altered intesti-
nal TER compared with their controls, indicating that 
changes have occurred in intestinal integrity and junc-
tion organization (Albin et al., 2007). Furthermore, 
treatment with the n-3 fatty acids, eicosapentanoic acid 
and docosahexaenoic acid, has effectively been shown 
to prevent reduced TER induced by the proinfl ammatory 
cytokines, interferon-γ, and TNF-α and prevent the re-
distribution of occludin and ZO-1 (Li et al., 2008). Also, 
docosahexaenoic acid treatment of Caco-2 monolayers 
has been shown to increase paracellular permeability via 
the intracellular redistribution of the tight junction pro-
teins (Roig-Pérez et al., 2004).
The second route of intestinal endotoxin and bac-
teria transport is via transcellular transport occurring 
through the epithelial cells (Tomita et al., 2004; Neal et 
al., 2006). Further, evidence indicates that lipid rafts are 
required for the recruitment of TLR4 and that receptor-
mediated endocytosis is a key mechanism of transcellu-
lar transport of bacteria and endotoxin in many cell types 
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(Triantafi lou et al., 2002; Ancuta et al., 2008; Chassin et 
al., 2008). Initially, it was thought that IEC did not have 
the necessary receptors to recognize the innate immune 
ligands such as MAMP and damage-associated molecu-
lar patterns. However, research over the past 10 yr has 
discovered that IEC do play a major role in the recogni-
tion of pathogens and endotoxin, and IEC express spe-
cifi c receptors, including TLR, nucleotide oligomeriza-
tion domain receptors, and retinoic acid-inducible gene 1 
protein (RIG)-I-like receptors (Cario et al., 2000; Cario, 
2005; Santaolalla et al., 2011). Almost all of the TLR, 
which are present in the immune cells, have been de-
scribed in human IEC (Abreu, 2010a). The confounding 
issue regarding the presence of TLR in IEC is that they 
are expressed on the apical side of the membrane; how-
ever, they are not believed to be continually activated by 
the presence of luminal endotoxin. Research with IEC 
has shown that TLR4 is present on the apical and baso-
lateral membranes as well as within the golgi apparatus 
(Hornef et al., 2003; Cario and Podolsky, 2006; Abreu, 
2010b). However, the overall consensus regarding the 
TLR4 location and expression indicates that IEC have a 
hyporesponsiveness toward endotoxin and that the loca-
tion of TLR4 within the cell may be a major contributing 
factor for the hyporesponsiveness (Vamadevan, 2010).
Both paracellular and transcellular routes of transport 
are two important ways through which most of the endo-
toxin enters systemic circulation from the gut. The gut is 
the fi rst line of defense against endotoxin and, if compro-
mised via nutrition, stress or metabolic state, endotoxin 
transport can increase (Suganuma et al., 2002; Clark et 
al., 2009; Liu et al., 2009). A greater understanding of 
gut endotoxin transport (Figure 2) will allow for the de-
velopment of nutritional and pharmacological mitigation 
strategies to avert the negative effects of endotoxin and 
improve production effi ciencies in livestock.
ENDOTOXIN DETOXIFICATION
After crossing the intestinal barrier, endotoxin is 
transported by both lymph and blood; however, most 
of the endotoxin is transported to the liver through the 
portal vein where a major portion of the endotoxin de-
toxifi cation process occurs (Olofsson et al., 1986; Van 
Leeuwen et al., 1994; Lemaire et al., 1999). If the amount 
of endotoxin entering the gastrointestinal tract over-
whelms the detoxifi cation capacity of the liver, endo-
toxemia ensues (Olofsson et al., 1985). Mammals have 
developed an elaborate system to tolerate and detoxify 
endotoxin either at the mucosal surface or in systemic 
circulation. Endotoxin tolerance can also occur by the 
downregulation of proteins that participate in endotox-
in signaling and the innate immune response (Fan and 
Cook, 2004). Bile plays an important role in detoxify-
ing the endotoxin because of the detergent action of bile 
salts in the intestine lumen. Furthermore, after endotoxin 
detection by hepatocytes and Kupffer cells, active and 
inactive forms of endotoxin may be transferred to the 
bile and excreted into the lumen (Maitra et al., 1981; 
Lóránd, 2004). Approximately 7% of the absorbed endo-
toxin is excreted through bile. Munford (2005) describes 
4 mechanisms through which endotoxin may be neutral-
ized. First, there are molecules that bind endotoxin and 
prevent it from engaging TLR4. Second, there are en-
zymes that degrade lipid A to decrease its activity. Third, 
endotoxin can be deactivated after its uptake by the liver. 
Fourth, there are target cell adaptations that modify the 
response to endotoxin. Moreover, reports show that incu-
bation of endotoxin with plasma makes it less pyrogenic 
and less infl ammatory (Rall et al., 1957; Rudbach and 
Johnson, 1964; Ulevitch and Johnston, 1978). Specifi c 
plasma proteins are able to bind endotoxin, and this is 
speculated to aid in the inactivation and detoxifi cation of 
endotoxin (Rudbach and Johnson, 1966; Johnson et al., 
1977; Brade and Brade, 1985). An example of a plasma 
protein includes serum amyloid A. This acute phase pro-
tein has been shown to increase during the acute phase 
response, binds to endotoxin monomers, and eliminates 
this toxin via the liver (Coetzee et al., 1986; Emmanuel 
et al., 2008). Additionally, antibodies such as collectins, 
along with bactericidal permeability-increasing protein 
and neutrophil granules, are plasma proteins that bind 
and neutralize endotoxin (Chaby, 2004; Munford, 2005).
Intestinal chylomicrons, which are involved in trans-
porting the absorbed fatty acids, have been shown to pro-
mote the absorption of endotoxin (Ghoshal et al., 2009). 
However, chylomicrons have been reported to mitigate the 
toxic effects of endotoxin by binding the endotoxin and 
promoting its inactivation via contact and the action of bile 
(Harris et al., 1993; Read et al., 1993). Further, LBP can 
bind to the chylomicrons and enhance the binding of endo-
toxin to the chylomicrons, which helps in reducing its bio-
activity (Vreugdenhil et al., 2003). Binding of endotoxin 
to the chylomicron helps in its recognition by low density 
lipoproteins (LDL) and LDL-associated receptors present 
in hepatocytes, which promote the endocytosis of endo-
toxin into the cell and its rapid clearance from circulation 
(Harris et al., 2002). Presence of apolipoprotein E in the 
chylomicrons is also protective against endotoxin because 
it delivers the endotoxin directly to hepatocytes, bypassing 
Kupffer cells and their proinfl ammatory cytokine produc-
tion (Van Oosten et al., 2001). Endotoxin is also found 
to bind with high density lipoprotein (HDL; Ulevitch et 
al., 1979). The role of HDL in detoxifying the endotoxin 
seems to be controversial. It is suggested that HDL aids in 
sequestering and detoxifying endotoxin but makes it more 
diffi cult to clear from circulation (Vreugdenhil et al., 2003; 
Birjmohun et al., 2007). Further, endotoxin may be trans-
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ferred from HDL to LDL with the help of LBP and phos-
pholipid transfer proteins. The transfer of endotoxin to LDL 
results in dyslipidemia and the loss of the capacity of HDL 
to bind cholesterol (Levels et al., 2005).
A major detoxifi cation mechanism for endotoxin is by 
enzyme modifi cation via acyloxyacyl hydrolase (AOAH). 
This hydrolase enzyme is classifi ed as a lipase and is pres-
ent in macrophages, dendritic cells, neutrophils, hepatic, 
liver, and renal cortical tubule cells (Erwin and Munford, 
1991). Interestingly, AOAH can be produced by the renal 
cortical tubule cells where it is secreted into the urine and 
can deacylate LPS and neutralize endotoxin (Feulner et 
al., 2004). Acyloxyacyl hydrolase selectively removes the 
secondary fatty acyl chains attached to the primary chains 
in the lipid A moiety, producing an LPS structure that is 
capable of binding MD2/TLR4 but does not initiate the 
signal or only can be a partial agonist (Lu et al., 2005). 
It is believed that AOAH has a role in mediating mac-
rophage tolerance to endotoxin because AOAH mRNA 
abundance is increased in endotoxin-primed and -toler-
ant macrophages versus endotoxin-naïve macrophages 
(Mages et al., 2007). When compared with wild-type mice, 
mice that lack AOAH and are challenged with endotoxin 
have enlarged livers and sustained hepatic cytokine pro-
duction, indicating that this enzyme prevents prolonged 
infl ammatory reaction to endotoxin (Shao et al., 2011). 
Regarding agriculturally relevant species, AOAH activity 
is increased during localized infl ammation in cattle, and 
its activity has been localized to neutrophils (McDermott 
and Fenwick, 1992). The regulation of AOAH by stress-
ors and diet, together with its direct role in intestinal de-
toxifi cation, warrants further investigation in livestock.
Further evidence that enzyme modifi cation plays a 
role in endotoxin neutralization and detoxifi cation is sup-
plied by recent reports that intestinal alkaline phosphatase 
(AP) directly deactivates endotoxin (Bates et al., 2007; 
Goldberg et al., 2008). Mechanistically, AP deactivates 
endotoxin by dephosphorylating the diphosphoryl moi-
ety of lipid A, rendering it inactive (Poelstra et al., 1997; 
Koyama et al., 2002; Munford et al., 2009). Alkaline 
phosphatase had been shown to inactivate endotoxin in 
zebra fi sh (Bates et al., 2007) and its activity is increased 
in infl amed intestinal tissue (Sánchez de Medina et al., 
2004). Also, debate exists regarding how AP dephosphor-
Figure 2. A summary of the effect of intestinal endotoxin transport and infl ammation on gut integrity and function. Gram-negative bacteria in the intestine 
releases endotoxin during growth, division, and death (1). Endotoxin may be free or bound to proteins such as lipopolysaccharide binding protein (LBP) in the 
lumen. Recruitment of toll-like receptor 4 (TLR4) and associated proteins to membrane lipid raft regions allows receptor-mediated endocytosis of bacteria and 
endotoxin in cells (2). Intracellular endotoxin may be transported bound to organelles (i.e., golgi) or albumin proteins in the cytosol (3). Opening of tight junc-
tions (TJ) and increased paracellular transport of endotoxin (4) can occur because of intestinal infl ammation or stress. Increased proinfl ammatory cytokine secre-
tion and activation of innate and adaptive immune cells and intestinal infl ammation occurs from endotoxin transported across the intestinal barrier (5). Secreted 
cytokines may enter the intestinal epithelial cells through the basolateral side, resulting in increased infl ammation and the activation of myosin light chain kinase 
and phosphorylate-myosin light chain. Together, this causes the disruption of TJ complexes (6) and increased paracellular endotoxin transport. After sensing of 
endotoxin via TLR4, suppression of nutrient transport and enteroendocrine cell signaling (7) can reduce appetite via the depolarization and secretion of appetite-
regulating neuropeptides such as cholecystokinin and glucagon-like peptide 1. 
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ylates endotoxin, and evidence is limited in livestock as 
to its role in detoxifi cation. The expression and activity 
of intestinal AP can be modulated by stress and dietary 
factors (Lallès, 2010). Dietary lipids regulate the activ-
ity of intestinal AP. For example, jejunal AP activity was 
greater in pigs fed a diet high in saturated fat (i.e., 15% 
beef tallow) than in pigs fed a diet high in unsaturated 
fat (i.e., 15% corn oil; Dudley et al., 1994). Another ex-
ample indicating that AP is regulated by dietary lipids is 
that cod liver oil rich in n-3 fatty acid has been shown to 
increase the secretion of intestinal AP (Kaur et al., 2007). 
Interestingly, this may be explained by the increased ex-
pression resolvin-E1, an antiinfl ammatory n-3 fatty acid 
lipid mediator, which induces AP activity (Campbell et al., 
2010). Furthermore, increased dietary fat consumption re-
duces intestinal AP activity in obesity-prone rodents (de 
La Serre et al., 2010). Interestingly, the decrease in ileal 
AP activity is associated with an increase in plasma endo-
toxin and increased infl ammation as assessed by myelo-
peroxidase activity (de La Serre et al., 2010).
Mechanistically, the alteration of intestinal AP by 
dietary lipids may be mediated by proinfl ammatory 
cytokines such as IL-1β and TNF-α, which inhibit the 
induction of AP (Malo et al., 2006). Stress and disease 
in livestock may decrease intestinal AP via reductions 
in feed intake (Goldberg et al., 2008; Lallès and David, 
2011). It has been observed that weaning pigs at a young 
age (i.e., 10 d) decreases both the expression and activ-
ity of AP in the jejunum (Lackeyram et al., 2010). This 
same age period near weaning is also associated with 
decreased feed intake and increased intestinal proin-
fl ammatory cytokine expression (Pié et al., 2004), both 
of which are perhaps responsible for decreased intestinal 
AP expression and activity that occurs with weaning in 
pigs. Altogether, dietary factors and stressors likely af-
fect intestinal and systemic infl ammation and endotoxin 
concentrations via alterations in mechanisms of detoxi-
fi cation and neutralization.
IMPLICATIONS OF INTESTINAL ENDOTOXIN 
AND INFLAMMATION
The gastrointestinal tract is the major site of nutri-
ent uptake. The nutrient transport function of the GIT 
decreases when the intestine is under prolonged im-
mune or metabolic stress. A study looking at absorp-
tive function of the small intestine during endotoxemia 
showed that Na and Cl ions, as well as glucose absorp-
tion, were decreased after 24 h of the challenge (Kanno 
et al., 1996). Further, marked epithelial infl ammation 
occurs around 6 h after challenge and villous atrophy 
occurs at 24 h; however, there are signs of recovery 
after 7 d. It has also been shown that endotoxin chal-
lenge results in decreased absorption of various sugars 
and AA (Meng et al., 2005; Albin et al., 2007; Flinn et 
al., 2010). One mechanism for this decreased transport 
might be through the inhibition of Na-dependent system 
of transport as well as a decrease in the Na+/K+ ATPase 
activity (Abad et al., 2001; García-Herrera et al., 2003; 
Amador et al., 2007a). Further, the proinfl ammatory cy-
tokine TNF-α has been shown to decrease the absorption 
of galactose (Amador et al., 2007b). Interestingly, intes-
tinal nutrient transport, when challenged with endotoxin, 
is divergently altered depending on the breed of animal 
(Albin et al., 2007). Overall, the endotoxin-mediated in-
hibition of nutrient absorption seems to be manifested 
by several interrelated signaling cascades, including 
those involving protein kinase C, protein kinase A, and 
mitogen-activated protein kinases, as well as proteasom-
al degradation (Amador et al., 2008; García-Herrera et 
al., 2008). While the animal itself tries to fi ght the cause 
of the stress, the intestine develops a reduced ability to 
transport nutrients and carry out other functions. The 
end result is an increased catabolic cascade and degra-
dation of muscle proteins (Webel et al., 1998; Daiwen 
et al., 2008) to support gluconeogenesis and increased 
whole-body metabolic energy demands.
Because of its strategic position between the luminal 
microbes and essentially sterile systemic circulation, the 
intestine needs to possess excellent immune capabilities 
to defend against any pathogenic attack. Thus, evolu-
tionarily, the intestine developed an extensive immune 
system network. The gastrointestinal tract can be clas-
sifi ed as the largest immune organ in the body (Collins 
et al., 1998; Fiocchi, 2003). Specifi c lymph nodes that 
are part of gut-associated lymphoid tissue are placed 
in the submucosal layer to defend against any invad-
ing pathogens. A variety of mononuclear phagocytes, 
such as monocytes-macrophages and dendritic cells, are 
present in the gut-associated lymphoid tissue as well as 
dispersed throughout the subepithelial connective tissue, 
the lamina propria. These immune cells, when isolated 
during intestinal infl ammation, display proinfl ammatory 
profi les and secrete cytokines such as TNF-α (Bar-On 
et al., 2011). A typical intestinal infl ammatory response 
progresses through the following steps. A leaky intesti-
nal epithelial barrier allows luminal commensal organ-
ism components to enter the submucosa and stimulate 
the immune system. The dendritic cells, through their 
pattern recognition receptor, recognize these commen-
sal constituents as pathogen components and initiate 
the differentiation of T cells and natural killer cells. The 
immune cells can also be activated by their own pat-
tern recognition receptors. This leads to the secretion of 
regulatory cytokines by T cells, which in turn stimulate 
the secretion of TNF-α, IL-1, and IL-6 by macrophages. 
Natural killer cells also play an active role by secreting 
cytokines as well as causing tissue damage (Baumgart 
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and Carding, 2007). The interplay of all these immune 
cells, endotoxin, and cytokines secretion can augment 
the infl ammatory state of the intestine.
During an infl ammatory response, the nutrient par-
titioning is redirected toward meeting the metabolic re-
quirements of the immune system. Infl ammation is as-
sociated with increase in body temperature; an increase 
of 1°C equates to a 13% increase in the basal metabo-
lism (Kluger, 1978). The increase in the concentrations 
of proinfl ammatory cytokines such as TNF-α and IL-1β 
have been shown to decrease feed consumption (Plata-
Salamán et al., 1996), rates of BW gain, and effi ciency of 
feed utilization (Evock-Clover et al., 1997; Steiger et al., 
1999). Thus, endotoxin-associated infl ammation results in 
an estimated 30% increase in energetic costs and leads 
to a signifi cant negative nitrogen balance because of pro-
tein breakdown and decreased BW gain (Lochmiller and 
Deerenberg, 2000). Further, multiple immune challenges 
occurring simultaneously lead to a cumulative reduction 
in performance (Hanssen et al., 2004).
All the evidence indicates that a signifi cant decrease 
in feed intake occurs during an immune challenge. 
Appetite regulation is a complex process, and it occurs 
mainly through neuronal control through the vagus nerve 
or through hormonal control via the secretion of leptin, 
ghrelin, cholecystokinin, and glucagon-like peptide 1. 
The hypothalamus receives and integrates these signals 
and brings about the desired effect of altered appetite 
control (Cummings, 2006; Sartin et al., 2011). The appe-
tite regulation under an immune challenge might occur 
through either one or both of these mechanisms. During 
most disease conditions in livestock a reduction in feed 
intake is accompanied by an increase in metabolic rate, 
which is signifi cantly different than fasting because dur-
ing fasting the decrease in feed intake is accompanied 
by decreased metabolic rate (Sartin et al., 2011). The 
infl ammatory cytokines secreted upon an immune chal-
lenge decrease feed intake and nutrient transport by act-
ing on the ST axis (Johnson, 1997, 1998). Tumor necro-
sis factor-α has been shown to be present in the central 
nervous system after an immune challenge with endo-
toxin, which indicates that it could act on the appetite 
regulatory center directly (Sakumoto et al., 2003). The 
appetite-stimulating neurotransmitters in the hypothala-
mus, such as neuropeptide Y and Agouti-related protein, 
may be reduced or unchanged, whereas appetite-inhib-
iting neurotransmitters, including proopiomelanocortin 
and cocaine- and amphetamine-regulated transcript, are 
increased during immune challenges. During disease 
stress, the latter may promote α-melanocyte stimulating 
hormone suppression of appetite via the MC4 recep-
tors to decrease appetite (Sartin et al., 2008, 2011). This 
mechanism of action results in typical sickness behavior 
such as decreased appetite and increased energy expen-
diture (Grossberg et al., 2010).
The other plausible mechanism by which appetite is 
regulated under an immune challenge and infl ammation 
is that endotoxin and other TLR4 ligands, such as SFA, 
have been shown to activate the enteroendocrine cells 
that act as nutrient sensors in the intestine. This leads 
to the secretion of appetite-regulating peptides, such 
as cholecytokinin and glucagon-like peptide 1, from 
the enteroendocrine cells that act on the satiety centers 
in the hypothalamus and ultimately results in reduced 
feed intake and nutrient absorption from the intes-
tine (Bogunovic et al., 2007; de Lartigue et al., 2011). 
Although this has been shown in the cell lines, further 
research is needed to prove this theory in whole animals.
SUMMARY AND CONCLUSION
The literature reviewed herein describes how lumi-
nal endotoxin is transported and its effects on gastro-
intestinal function and animal performance (Figure 2). 
Additionally, we briefl y describe plausible mechanisms 
of endotoxin detoxifi cation and neutralization. Even at 
low concentrations, endotoxin is a potent stimulator of 
proinfl ammatory cytokine production from various cell 
types within the body, not just immune-competent cells. 
The resulting immune activation and associated infl am-
mation makes endotoxin an important factor that is com-
monly overlooked in livestock production. However, 
more research is needed to understand how endotoxin is 
transported into circulation and its effect on metabolism 
and energetics. Additionally, research describing how 
stress and nutrition modulate endotoxin transport and 
clearance in agriculturally relevant species is warranted.
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